Chronic Insomnia Disorder across Europe: Expert Opinion on Challenges and Opportunities to Improve Care.

ABSTRACT: One in ten adults in Europe have chronic insomnia, which is characterised by frequent and persistent difficulties initiating and/or maintaining sleep and daily functioning impairments. Regional differences in practices and access to healthcare services lead to variable clinical care across Europe. Typically, a patient with chronic insomnia (a) will usually present to a primary care physician; (b) will not be offered cognitive behavioural therapy for insomnia-the recommended first-line treatment; (c) will instead receive sleep hygiene recommendations and eventually pharmacotherapy to manage their long-term condition; and (d) will use medications such as GABA receptor agonists for longer than the approved duration. Available evidence suggests that patients in Europe have multiple unmet needs

SUBMITTER: Ellis J 

PROVIDER: S-EPMC10001099 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature